Odemase Retard Uses

Did you have any side effects with this medicine?
sponsored

What is Odemase Retard?

Odemase Retard belongs to a group of medicines called loop diuretics (also known as water pills). Odemase Retard is given to help treat fluid retention (edema) and swelling that is caused by congestive heart failure, liver disease, kidney disease, or other medical conditions. It works by acting on the kidneys to increase the flow of urine.

Odemase Retard is also used alone or together with other medicines to treat high blood pressure (hypertension). High blood pressure adds to the workload of the heart and arteries. If it continues for a long time, the heart and arteries may not function properly. This can damage the blood vessels of the brain, heart, and kidneys, resulting in a stroke, heart failure, or kidney failure. High blood pressure may also increase the risk of heart attacks. These problems may be less likely to occur if blood pressure is controlled.

Odemase Retard is available only with your doctor's prescription.

Odemase Retard indications

sponsored

Parenteral therapy should be reserved for patients unable to take oral medication or for patients in emergency clinical situations.

Edema: Odemase Retard is indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. Odemase Retard is particularly useful when an agent with greater diuretic potential is desired.

Odemase Retard is indicated as adjunctive therapy in acute pulmonary edema. The intravenous administration of Odemase Retard is indicated when a rapid onset of diuresis is desired, e.g., in acute pulmonary edema.

If gastrointestinal absorption is impaired or oral medication is not practical for any reason, Odemase Retard is indicated by the intravenous or intramuscular route.

Parenteral use should be replaced with oral Odemase Retard as soon as practical.

How should I use Odemase Retard?

Use Odemase Retard solution as directed by your doctor. Check the label on the medicine for exact dosing instructions.

Ask your health care provider any questions you may have about how to use Odemase Retard solution.

Uses of Odemase Retard in details

sponsored

Odemase Retard is used to reduce extra fluid in the body (edema) caused by conditions such as heart failure, liver disease, and kidney disease. This can lessen symptoms such as shortness of breath and swelling in your arms, legs, and abdomen.

This drug is also used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems.

Odemase Retard is a "water pill" (diuretic) that causes you to make more urine. This helps your body get rid of extra water and salt.

OTHER USES: This section contains uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care professional. Use this drug for a condition that is listed in this section only if it has been so prescribed by your health care professional.

This medication may also be used to decrease a high level of calcium in the blood (hypercalcemia).

How to use Odemase Retard

Read the Patient Information Leaflet if available from your pharmacist before you start taking Odemase Retard and each time you get a refill. If you have any questions, ask your doctor or pharmacist.

Take this medication by mouth as directed by your doctor, with or without food, usually once or twice daily. It is best to avoid taking this medication within 4 hours of your bedtime to prevent having to get up to urinate.

Dosage is based on your medical condition, age, and response to treatment. For children, the dose is also based on weight. Older adults usually start with a lower dose to decrease the risk of side effects. Do not increase your dose or take it more often than directed.

Take this medication regularly in order to get the most benefit from it. To help you remember, take it at the same time(s) of the day as directed. It is important to continue taking this medication even if you feel well. Most people with high blood pressure do not feel sick.

Sucralfate, cholestyramine, and colestipol can decrease the absorption of Odemase Retard. If you are taking any of these drugs, separate the timing of each dose from Odemase Retard by at least 2 hours.

Tell your doctor if your condition does not improve or if it worsens (for example, your blood pressure readings remain high or increase).

Odemase Retard description

sponsored

A topical anti-infective agent effective against gram-negative and gram-positive bacteria. It is used for superficial wounds, burns, ulcers, and skin infections. Odemase Retard has also been administered orally in the treatment of trypanosomiasis.

Odemase Retard dosage

Odemase Retard Dosage

Generic name: Odemase Retard 20mg

Dosage form: tablet

The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.

Edema

Therapy should be individualized according to patient response to gain maximal therapeutic response and to determine the minimal dose needed to maintain that response.

Adults -- The usual initial dose of Odemase Retard is 20 to 80 mg given as a single dose. Ordinarily a prompt diuresis ensues. If needed, the same dose can be administered 6 to 8 hours later or the dose may be increased. The dose may be raised by 20 or 40 mg and given not sooner than 6 to 8 hours after the previous dose until the desired diuretic effect has been obtained. The individually determined single dose should then be given once or twice daily (eg, at 8 am and 2 pm). The dose of Odemase Retard may be carefully titrated up to 600 mg/day in patients with clinically severe edematous states.

Edema may be most efficiently and safely mobilized by giving Odemase Retard on 2 to 4 consecutive days each week.

When doses exceeding 80 mg/day are given for prolonged periods, careful clinical observation and laboratory monitoring are particularly advisable.

Geriatric patients -- In general, dose selection for the elderly patient should be cautious, usually starting at the low end of the dosing range.

Pediatric patients -- The usual initial dose of oral Odemase Retard in pediatric patients is 2 mg/kg body weight, given as a single dose. If the diuretic response is not satisfactory after the initial dose, dosage may be increased by 1 or 2 mg/kg no sooner than 6 to 8 hours after the previous dose. Doses greater than 6 mg/kg body weight are not recommended. For maintenance therapy in pediatric patients, the dose should be adjusted to the minimum effective level.

Hypertension

Therapy should be individualized according to the patient’s response to gain maximal therapeutic response and to determine the minimal dose needed to maintain the therapeutic response.

Adults -- The usual initial dose of Odemase Retard for hypertension is 80 mg, usually divided into 40 mg twice a day. Dosage should then be adjusted according to response. If response is not satisfactory, add other antihypertensive agents.

Changes in blood pressure must be carefully monitored when Odemase Retard is used with other antihypertensive drugs, especially during initial therapy. To prevent excessive drop in blood pressure, the dosage of other agents should be reduced by at least 50% when Odemase Retard is added to the regimen. As the blood pressure falls under the potentiating effect of Odemase Retard, a further reduction in dosage or even discontinuation of other antihypertensive drugs may be necessary.

Geriatric patients -- In general, dose selection and dose adjustment for the elderly patient should be cautious, usually starting at the low end of the dosing range.

More about Odemase Retard (Odemase Retard)

Consumer resources

Professional resources

Related treatment guides

Odemase Retard interactions

See also:
What other drugs will affect Odemase Retard?

sponsored

Apo-Odemase Retard may increase the ototoxic potential of aminoglycoside antibiotics, especially in the presence of impaired renal function. Except in life-threatening situations, avoid this combination.

Apo-Odemase Retard should not be used concomitantly with ethacrynic acid because of the possibility of ototoxicity. Patients receiving high doses of salicylates concomitantly with Odemase Retard, as in rheumatic disease, may experience salicylate toxicity at lower doses because of competitive renal excretory sites.

Apo-Odemase Retard has a tendency to antagonize the skeletal muscle relaxing effect of tubocurarine and may potentiate the action of succinylcholine.

Lithium generally should not be given with diuretics because they reduce lithiums renal clearance and add a high risk of lithium toxicity.

Apo-Odemase Retard may add to or potentiate the therapeutic effect of other antihypertensive drugs. Potentiation occurs with ganglionic or peripheral adrenergic blocking drugs.

Apo-Odemase Retard may decrease arterial responsiveness to norepinephrine. However, norepinephrine may still be used effectively.

Tablets

Simultaneous administration of sucralfate and Odemase Retard tablets may reduce the natriuretic and antihypertensive effects of Odemase Retard. Patients receiving both drugs should be observed closely to determine if the desired diuretic and/or antihypertensive effect of Odemase Retard is achieved. The intake of Odemase Retard and sucralfate should be separated by at least two hours.

Tablets, Injection, and

Oral Solution

One study in six subjects demonstrated that the combination of Odemase Retard and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency. There are case reports of patients who developed increased BUN, serum creatinine and serum potassium levels, and weight gain when Odemase Retard was used in conjunction with NSAIDs.

Literature reports indicate that coadministration of indomethacin may reduce the natriuretic and antihypertensive effects of Odemase Retard in some patients by inhibiting prostaglandin synthesis. Indomethacin may also affect plasma renin levels, aldosterone excretion, and renin profile evaluation. Patients receiving both indomethacin and Odemase Retard should be observed closely to determine if the desired diuretic and/or antihypertensive effect of Odemase Retard is achieved.

Odemase Retard side effects

See also:
What are the possible side effects of Odemase Retard?

Applies to Odemase Retard: oral solution, oral tablet

Other dosage forms:

In addition to its needed effects, some unwanted effects may be caused by Odemase Retard (the active ingredient contained in Odemase Retard). In the event that any of these side effects do occur, they may require medical attention.

Major Side Effects

You should check with your doctor immediately if any of these side effects occur when taking Odemase Retard:

Rare

Incidence not known:

If any of the following symptoms of overdose occur while taking Odemase Retard, get emergency help immediately:

Symptoms of overdose:

Minor Side Effects

Some of the side effects that can occur with Odemase Retard may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:

Incidence not known:

Odemase Retard contraindications

See also:
What is the most important information I should know about Odemase Retard?

Hypersensitivity to Odemase Retard or any component of the formulation; anuria

Canadian labeling: Additional contraindications (not in US labeling): Hypersensitivity to sulfonamide-derived drugs; complete renal shutdown; hepatic coma and precoma; uncorrected states of electrolyte depletion, hypovolemia, dehydration, or hypotension; jaundiced newborn infants or infants with disease(s) capable of causing hyperbilirubinemia and possibly kernicterus; breast-feeding. Note: Manufacturer labeling for Odemase Retard Special and Odemase Retard Special Injection also includes: GFR <5 mL/minute or GFR >20 mL/minute; hepatic cirrhosis; renal failure accompanied by hepatic coma and precoma; renal failure due to poisoning with nephrotoxic or hepatotoxic substances.

Note: Although the approved product labeling states this medication is contraindicated with other sulfonamide-containing drug classes, the scientific basis of this statement has been challenged. See “Warnings/Precautions” for more detail.



Active ingredient matches for Odemase Retard:

Furosemide


Unit description / dosage (Manufacturer)Price, USD
Capsule, Retard; Oral; Furosemide 30 mg
Capsules, Retard; Oral; Furosemide 30 mg

List of Odemase Retard substitutes (brand and generic names):

Tablets; Oral; Furosemide 500 mg (Azupharma)
Injectable; Injection; Furosemide 10 mg / ml (Mepha)
Tablet; Oral; Furosemide 40 mg (Mepha)
Tablets; Oral; Furosemide 40 mg (Mepha)
Pharmaniaga Frusemide 40 mg x 50 x 10's
Phil Pharmawealth/Atlantic Furosemide / amp 10 mg/1 mL x 2 mL x 25's (Atlantic Lab)
Phil Pharmawealth/Atlantic Furosemide 10 mg/1 mL x 2 mL x 100's (Atlantic Lab)
Phil Pharmawealth/Atlantic Furosemide inj 10 mg/mL 2 mL x 100 x 1's (Atlantic Lab)
Phil Pharmawealth/Atlantic Furosemide inj 10 mg/mL 2 mL x 25 x 1's (Atlantic Lab)
Phil Pharmawealth/Karnataka Furosemide / amp 10 mg/1 mL x 2 mL x 10's (Karnataka)
Phil Pharmawealth/Karnataka Furosemide inj 10 mg/mL 2 mL x 10 x 1's (Karnataka)
Pisamor 40 mg x 100's
Tablet; Oral; Furosemide 20 mg
Tablet; Oral; Furosemide 40 mg
Tablets; Oral; Furosemide 20 mg
Tablets; Oral; Furosemide 40 mg
PMS-furosemide tablet 20 mg (Pharmascience Inc (Canada))
PMS-furosemide tablet 40 mg (Pharmascience Inc (Canada))
Prosix 40 mg x 200's
Prosix 40 mg x 500's
Prosix 40 mg x 1, 000's
Rasitol 40 mg x 10's x 100 (Ysp)

References

  1. DailyMed. "FUROSEMIDE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
  2. PubChem. "furosemide". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
  3. DrugBank. "furosemide". http://www.drugbank.ca/drugs/DB00695 (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Odemase Retard are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Odemase Retard. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reported useful

No survey data has been collected yet


Consumer reported price estimates

No survey data has been collected yet


Consumer reported time for results

No survey data has been collected yet


Consumer reported age

No survey data has been collected yet


Consumer reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 16 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2024 ndrugs.com All Rights Reserved